EA199901111A1 - DERIVATIVES OF HYDRAZINE - Google Patents

DERIVATIVES OF HYDRAZINE

Info

Publication number
EA199901111A1
EA199901111A1 EA199901111A EA199901111A EA199901111A1 EA 199901111 A1 EA199901111 A1 EA 199901111A1 EA 199901111 A EA199901111 A EA 199901111A EA 199901111 A EA199901111 A EA 199901111A EA 199901111 A1 EA199901111 A1 EA 199901111A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ness
alkyl
aryl
cycloalkyl
alkenyl
Prior art date
Application number
EA199901111A
Other languages
Russian (ru)
Inventor
Майкл Джон Айви Бродхэрст
Уилльям Хенри Джонсон
Дарил Саймон Уолтер
Original Assignee
Ф.Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф.Хоффманн-Ля Рош Аг filed Critical Ф.Хоффманн-Ля Рош Аг
Priority claimed from PCT/EP1998/003683 external-priority patent/WO1999001428A1/en
Publication of EA199901111A1 publication Critical patent/EA199901111A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/48Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
    • C07C311/49Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

В заявке описаны гидразиновые производные формулы (I)в которой Y обозначает CO или SO,Rобозначает (низш.)алкил, (низш.)алкенил, (низш.)циклоалкил, (низш.)циклоалкил (низш.)алкил, арил или арил(низш.)алкил;Rобозначает (низш.)алкил, галоид (низш.)алкил, арил(низш.)алкил, арил(низш.)алкенил или арил, когда Y обозначает SO, и обозначает (низш.)алкил, галоид (низш.)алкил, (низш.)алкокси, (низш.)алкоксикарбонил, ацил, (низш.)циклоалкил, арил, арил(низш.)алкил, арил(низш.)алкокси или NRR, когда Y обозначает CO,Rобозначает водород, (низш.)алкил, необязательно замещенный циано-, аминогруппой, гидроксилом, (низш.)алкокси, (низш.)алкоксикарбонилом, гетероциклилом или гетероциклилкарбонилом, (низш.)алкенил, (низш.)алкинил, (низш.)циклоалкил, (низш.)циклоалкил(низш.)алкил, арил(низш.)алкил, арил(низш.)алкенил, арил или гетероциклил илиRи Rсовместно образуют остаток 5-, 6- или 7-членной циклической амидной, циклической имидной, циклической сульфонамидной или циклической уретановой группы,Rобозначает (низш.)алкил, гидрокси(низш.)алкил, (низш.)алкенил, (низш.)циклоалкил, (низш.)циклоалкил(низш.)алкил или группировку формулы Х-арил, Х-гетероарил или -(CH)-CH=CRR,X обозначает спейсер,Rи Rкаждый независимо друг от друга обозначает водород, (низш.)алкил или арил(низш.)алкил иRи Rсовместно образуют (низш.)алкиленовую группу, в которой одна метиленовая группа необязательно замещена гетероатомом,и их фармацевтически приемлемые соли, которые ингибируют не только выделение из клеток фактора некроза опухоли (ФНО-α) и трансформирующего фактора роста (ТФР-α), но также пролиферацию кератиноцитов. Они могут быть использованы в качестве лекарственных средств, прежде всего при лечении воспалительных процессов, лихорадки, кровотечений, сепсиса, ревматоидногоThe application describes hydrazine derivatives of formula (I) in which Y represents CO or SO, R denotes (lower) alkyl, (lower) alkenyl, (lower) cycloalkyl, (lower) cycloalkyl, (lower) alkyl, aryl or aryl (lower) alkyl; R 4 is lower alkyl, halo (lower) alkyl, aryl (lower) alkyl, aryl (lower) alkenyl, or aryl, when Y is SO, and is lower alkyl, halogen (ness.) alkyl, (ness.) alkoxy, (ness.) alkoxycarbonyl, acyl, (ness.) cycloalkyl, aryl, aryl (ness.) alkyl, aryl (ness.) alkoxy or NRR, when Y represents CO, R is hydrogen, (ness.) alkyl, optionally substituted cyano-, amino, hydroxy, (ness.) alkoxy, (ness.) alkoxycarbonyl, heterocyclyl or heterocyclylcarbonyl, (ness.) alkenyl, (ness.) alkynyl, (ness.) cycloalkyl, (ness.) cycloalkyl (ness.) alkyl, aryl lower alkyl, aryl lower alkenyl, aryl or heterocyclyl or R and R together form a residue of a 5-, 6- or 7-membered cyclic amide, cyclic imide, cyclic sulfonamide or cyclic urethane group, R means (lower) alkyl, hydroxy (ness.) alkyl, (ness.) alkenyl, (ness.) cycloalkyl, (ness.) cycloalkyl (ness.) alkyl or a group of the formula X-aryl, X- etheroaryl or - (CH) -CH = CRR, X is a spacer, R and R each independently of one another denotes hydrogen, (lower) alkyl or aryl (lower) alkyl, and R and R together form a (lower) alkylene group, in which one methylene the group is optionally substituted with a heteroatom, and their pharmaceutically acceptable salts, which inhibit not only the release of tumor necrosis factor (TNF-α) and transforming growth factor (TGF-α) from cells, but also the proliferation of keratinocytes. They can be used as medicines, especially in the treatment of inflammatory processes, fever, bleeding, sepsis, rheumatoid

EA199901111A 1997-06-30 1998-06-18 DERIVATIVES OF HYDRAZINE EA199901111A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9713833.3A GB9713833D0 (en) 1997-06-30 1997-06-30 Novel hydrazine derivatives
GBGB9803335.0A GB9803335D0 (en) 1997-06-30 1998-02-17 Novel hydrazine derivatives
PCT/EP1998/003683 WO1999001428A1 (en) 1997-06-30 1998-06-18 Hydrazine derivatives

Publications (1)

Publication Number Publication Date
EA199901111A1 true EA199901111A1 (en) 2000-08-28

Family

ID=10815174

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199901111A EA199901111A1 (en) 1997-06-30 1998-06-18 DERIVATIVES OF HYDRAZINE

Country Status (10)

Country Link
KR (1) KR100371122B1 (en)
AR (1) AR012258A1 (en)
CO (1) CO4940511A1 (en)
EA (1) EA199901111A1 (en)
GB (2) GB9713833D0 (en)
HR (1) HRP980366A2 (en)
PE (1) PE86099A1 (en)
UA (1) UA58561C2 (en)
YU (1) YU70899A (en)
ZA (1) ZA985469B (en)

Also Published As

Publication number Publication date
CO4940511A1 (en) 2000-07-24
KR20010014331A (en) 2001-02-26
AR012258A1 (en) 2000-09-27
ZA985469B (en) 1998-12-30
GB9713833D0 (en) 1997-09-03
UA58561C2 (en) 2003-08-15
PE86099A1 (en) 1999-09-17
KR100371122B1 (en) 2003-02-05
GB9803335D0 (en) 1998-04-15
YU70899A (en) 2002-06-19
HRP980366A2 (en) 1999-02-28

Similar Documents

Publication Publication Date Title
IT1301792B1 (en) DERIVATIVES OF HYDRAZINE
AR045037A1 (en) TETRAHIDRO-1H-PIRAZOLO [3,4-C] SUBSTITUTED PYRIDINS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE.
DK0833839T3 (en) Heterocyclic peptidyl compounds useful in the treatment of thrombin-related diseases
DK70784D0 (en) QUINAZOLINYLOXYALKYLAMIDE DERIVATIVES
ATE242245T1 (en) PYRROLO(2,3-D)PYRIMIDINES AND THEIR USE AS TYROSINE KINASE INHIBITORS
ATE279391T1 (en) ANTI-FLAMMOTORIC INDOLE DERIVATIVES
DK0767793T3 (en) N-substituted (dihydroxyboryl) alkyl derivatives of purine, indole and pyrimidine which are useful as inhibitors of inflammatory cytokines
TR199802269T2 (en) Indole derivatives useful as endothelin receptor antagonists.
ES2186017T3 (en) PROCEDURES FOR THE PREPARATION OF DELTA 4,5-STEROIDS 3-CETO-7ALFA-ALCOXICARBONIL-SUBSTITUTES AND INTERMEDIATE COMPOUNDS OF USEFULNESS.
TR199902357T2 (en) New knowledge.
FR2712591B1 (en) New arylpiperazines derived from indole, their preparation and their therapeutic use.
UA35557C2 (en) 1,2,4- Oxadiazolyl-phenoxyalkylisoxazole DERIVATIVES having antiviral activity and pharmaceutical composition based thereon
FI951968A (en) New vitamin D analogues
DK0918777T3 (en) Selected derivatives of K-252a
DE69107064D1 (en) INDOLDER DERIVATIVES.
YU7191A (en) ORALLY ACTIVE RENIN INHIBITORS
EA199901111A1 (en) DERIVATIVES OF HYDRAZINE
NO954328L (en) Newly substituted 1-phenyl-pyridinyl-benzotriazoles
EA200000561A1 (en) TRIAZINE CONNECTIONS FOR THE TREATMENT OF CNS DISORDERS
DE69619259D1 (en) AMIDINE AND ISOTHIOURINE DERIVATIVES AS INHIBITORS OF THE NITROGEN OXIDE SYNTHASE
TR199701298T1 (en) Tetralins.
FI880548A0 (en) Process for the preparation of pharmacologically active 2-amino-N- (1,2-diphenylethyl) acetamide derivatives
ATE47135T1 (en) ANTICONVULSE AGENTS.
TR200003877T2 (en) Hiydroxamic acid derivatives, which are inhibitors of human CD23 production and TNF release
PT1104419E (en) AZABICYCLOHEPTAN DERIVATIVES SUBSTITUTED IN NITROGEN ITS PREPARATION AND UTILIZATION